<VariationArchive VariationID="282866" VariationName="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs)" VariationType="Duplication" Accession="VCV000282866" Version="18" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-03-30" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="267103" VariationID="282866">
      <GeneList>
        <Gene Symbol="FKRP" FullName="fukutin related protein" GeneID="79147" HGNC_ID="HGNC:17997" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46744760" stop="46758575" display_start="46744760" display_stop="46758575" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47249302" stop="47261831" display_start="47249302" display_stop="47261831" Strand="+" />
          </Location>
          <OMIM>606596</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024301.5(FKRP):c.162_165dup (p.Phe56fs)</Name>
      <CanonicalSPDI>NC_000019.10:46755610:GGGAG:GGGAGGGAG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46755610" stop="46755611" display_start="46755610" display_stop="46755611" variantLength="4" positionVCF="46755610" referenceAlleleVCF="C" alternateAlleleVCF="CGGGA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47258867" stop="47258868" display_start="47258867" display_stop="47258868" variantLength="4" positionVCF="47258867" referenceAlleleVCF="C" alternateAlleleVCF="CGGGA" />
      </Location>
      <ProteinChange>F56fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024301.4" sequenceAccession="NM_024301" sequenceVersion="4" change="c.162_165dupGGAG">
            <Expression>NM_024301.4:c.162_165dupGGAG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.46755612_46755615dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.46755612_46755615dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.47258869_47258872dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.47258869_47258872dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008898.2" sequenceAccession="NG_008898" sequenceVersion="2" change="g.14567_14570dup">
            <Expression>NG_008898.2:g.14567_14570dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001039885.3" sequenceAccession="NM_001039885" sequenceVersion="3" change="c.162_165dup">
            <Expression>NM_001039885.3:c.162_165dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001034974.1" sequenceAccession="NP_001034974" sequenceVersion="1" change="p.Phe56fs">
            <Expression>NP_001034974.1:p.Phe56fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024301.5" sequenceAccession="NM_024301" sequenceVersion="5" change="c.162_165dup" MANESelect="true">
            <Expression>NM_024301.5:c.162_165dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077277.1" sequenceAccession="NP_077277" sequenceVersion="1" change="p.Phe56fs">
            <Expression>NP_077277.1:p.Phe56fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_761" sequenceAccession="LRG_761">
            <Expression>LRG_761:g.14567_14570dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_761t1" sequenceAccession="LRG_761t1">
            <Expression>LRG_761t1:c.162_165dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_761p1" sequenceAccession="LRG_761p1" change="p.Phe56fs">
            <Expression>LRG_761p1:p.Phe56fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10604327" DB="ClinGen" />
        <XRef Type="rs" ID="886042506" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs) AND not provided" Accession="RCV000364855" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-03-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2I" Accession="RCV000665348" Version="1">
        <ClassifiedConditionList TraitSetID="1166">
          <ClassifiedCondition DB="MedGen" ID="C1846672">Autosomal recessive limb-girdle muscular dystrophy type 2I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs) AND Walker-Warburg congenital muscular dystrophy" Accession="RCV000812275" Version="8">
        <ClassifiedConditionList TraitSetID="31131">
          <ClassifiedCondition DB="MedGen" ID="C0265221">Walker-Warburg congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" Accession="RCV003463746" Version="1">
        <ClassifiedConditionList TraitSetID="1168">
          <ClassifiedCondition DB="MedGen" ID="C3150413">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024301.5(FKRP):c.162_165dup (p.Phe56fs) AND multiple conditions" Accession="RCV003224251" Version="1">
        <ClassifiedConditionList TraitSetID="10240">
          <ClassifiedCondition DB="MedGen" ID="C1846672">Autosomal recessive limb-girdle muscular dystrophy type 2I</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3150413">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847759">Muscular dystrophy-dystroglycanopathy type B5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-31" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11592034</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16476814</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18160674</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="31131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35635" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
                <XRef ID="Walker-Warburg+syndrome/7436" DB="Genetic Alliance" />
                <XRef ID="111504002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy, type A</ElementValue>
                <XRef ID="MONDO:0000171" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg syndrome</ElementValue>
                <XRef ID="899" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2599" />
                <XRef ID="2599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0265221" DB="MedGen" />
              <XRef ID="MONDO:0000171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10240" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10061" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+%28with+brain+and+eye+anomalies%29+type+A5/8068" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ElementValue>
                <XRef ID="MONDO:0013157" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15625" />
                <XRef ID="15625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A), which includes both the more severe Walker-Warburg syndrome (WWS) and the slightly less severe muscle-eye-brain disease (MEB), is an autosomal recessive disorder with characteristic brain and eye malformations, profound mental retardation, congenital muscular dystrophy, and death usually in the first years of life. It represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of DAG1 (128239), collectively known as 'dystroglycanopathies' (Beltran-Valero de Bernabe et al., 2004).
For a general phenotypic description and a discussion of genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see MDDGA1 (236670).</Attribute>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150413" DB="MedGen" />
              <XRef ID="MONDO:0013157" DB="MONDO" />
              <XRef Type="MIM" ID="613153" DB="OMIM" />
            </Trait>
            <Trait ID="5568" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, CONGENITAL, 1C</ElementValue>
                <XRef Type="MIM" ID="606612" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED</ElementValue>
                <XRef Type="MIM" ID="606612" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5</ElementValue>
                <XRef Type="MIM" ID="606612" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy type B5</ElementValue>
                <XRef ID="MONDO:0011688" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDC1C</ElementValue>
                <XRef Type="MIM" ID="606612" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MDDGB5</ElementValue>
                <XRef Type="MIM" ID="606612" DB="OMIM" />
              </Symbol>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="52428" DB="Orphanet" />
              <XRef ID="C1847759" DB="MedGen" />
              <XRef ID="MONDO:0011688" DB="MONDO" />
              <XRef Type="MIM" ID="606612" DB="OMIM" />
            </Trait>
            <Trait ID="5573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy-dystroglycanopathy, type C5</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2I</ElementValue>
                <XRef ID="MONDO:0011787" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGC5</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2I</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12533" />
                <XRef ID="12533" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="34515" DB="Orphanet" />
              <XRef ID="C1846672" DB="MedGen" />
              <XRef ID="MONDO:0011787" DB="MONDO" />
              <XRef Type="MIM" ID="607155" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10061" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+%28with+brain+and+eye+anomalies%29+type+A5/8068" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5</ElementValue>
                <XRef ID="MONDO:0013157" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA5</ElementValue>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15625" />
                <XRef ID="15625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A), which includes both the more severe Walker-Warburg syndrome (WWS) and the slightly less severe muscle-eye-brain disease (MEB), is an autosomal recessive disorder with characteristic brain and eye malformations, profound mental retardation, congenital muscular dystrophy, and death usually in the first years of life. It represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of DAG1 (128239), collectively known as 'dystroglycanopathies' (Beltran-Valero de Bernabe et al., 2004).
For a general phenotypic description and a discussion of genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see MDDGA1 (236670).</Attribute>
                <XRef Type="MIM" ID="613153" DB="OMIM" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150413" DB="MedGen" />
              <XRef ID="MONDO:0013157" DB="MONDO" />
              <XRef Type="MIM" ID="613153" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1166" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy-dystroglycanopathy, type C5</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606596.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2I</ElementValue>
                <XRef ID="MONDO:0011787" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGC5</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2I</ElementValue>
                <XRef Type="MIM" ID="607155" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12533" />
                <XRef ID="12533" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="34515" DB="Orphanet" />
              <XRef ID="C1846672" DB="MedGen" />
              <XRef ID="MONDO:0011787" DB="MONDO" />
              <XRef Type="MIM" ID="607155" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1539760" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="451297|OMIM:607155" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000789456" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18160674</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11592034</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGGGA" referenceAllele="C" start="47258867" stop="47258867" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024301.4:c.162_165dupGGAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607155" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="648090" SubmissionDate="2016-11-03" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="33900_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000334567" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="GGAG" referenceAllele="-" start="47258872" stop="47258873" variantLength="2" />
            <GeneLocation>NM_024301.4:Ex4</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI013888" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=FKRP</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7079913" SubmissionDate="2023-01-06" DateLastUpdated="2023-03-04" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="3349782|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003799593" DateUpdated="2023-03-04" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The FKRP c.162_165dup; p.Phe56GlyfsTer6 variant (rs886042506; also reported as 165InsGGAG; ClinVar Variation ID: 282866), has been previously identified in trans with other pathogenic variants in FKRP in at least two patients with symptoms of congenital muscular dystrophy and reduced glycosylated alpha-dystroglycan (Brockington 2001 and Peat 2008). This variant is only observed on two alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant results in a premature termination codon in the last (and only coding) exon of the FKRP gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein that would include a sequence of 6 amino acid residues not usually present. Additionally, several downstream truncating variants have been described in individuals with FKRP-related muscular dystrophy and are considered pathogenic (Selected references: Brockington 2001 and Matsumoto 2005). Based on the available information, the p.Phe56GlyfsTer6 variant is considered pathogenic. References: Brockington M et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet. 2001 Dec;69(6):1198-209. PMID: 11592034 Matsumoto H et al. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. Neuromuscul Disord. 2005 May;15(5):342-8. PMID: 15833426. Peat RA et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology. 2008 Jul 29;71(5):312-21. PMID: 18160674.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.47258869_47258872dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7328335" SubmissionDate="2023-04-18" DateLastUpdated="2023-04-30" DateCreated="2023-04-30">
        <ClinVarSubmissionID localKey="1961|OMIM:606612;607155;613153" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003919962" DateUpdated="2023-04-30" DateCreated="2023-04-30" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>FKRP NM_024301.4 ex 4 p.Phe56Glyfs*6 (c.162_165dup): This variant has been reported in the literature in at least one individual with autosomal congenital muscular dystrophy (Brockington 2001 PMID:11592034). This variant is present in 0.001% (2/104602) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/19-47258867-C-CGGGA) and is present in ClinVar, with several labs classifying this variant as pathogenic (Variation ID:282866). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant creates a premature stop codon 6 amino acids downstream from this location which results in an absent or abnormal protein. Loss of function variants have been reported in association with disease for this gene (Thornhill 2008 PMID:18477595). In summary, this variant is classified as pathogenic based on the data above.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="19" alternateAllele="CGGGA" referenceAllele="C" start="46755610" stop="46755610" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606612" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607155" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613153" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13087641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1846722" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="514238|MedGen:C0265221" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000952584" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16476814</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11592034</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18160674</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD 0.002%). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FKRP protein in which other variant(s) (p.Q460*) have been determined to be pathogenic (PMID: 16476814; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 282866). This premature translational stop signal has been observed in individuals with FKRP-related conditions (PMID: 11592034, 18160674). This sequence change creates a premature translational stop signal (p.Phe56Glyfs*6) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 440 amino acid(s) of the FKRP protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.47258867_47258868insGGGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265221" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7840355" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_024301.5:c.162_165dup|OMIM:613153" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004197408" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024301.5:c.162_165dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613153" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1539760" TraitType="Disease" MappingType="XRef" MappingValue="607155" MappingRef="OMIM">
        <MedGen CUI="C1846672" Name="Autosomal recessive limb-girdle muscular dystrophy type 2I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7328335" TraitType="Disease" MappingType="XRef" MappingValue="613153" MappingRef="OMIM">
        <MedGen CUI="C3150413" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7079913" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="648090" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1846722" TraitType="Disease" MappingType="XRef" MappingValue="C0265221" MappingRef="MedGen">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7328335" TraitType="Disease" MappingType="XRef" MappingValue="606612" MappingRef="OMIM">
        <MedGen CUI="C1847759" Name="Muscular dystrophy-dystroglycanopathy type B5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7840355" TraitType="Disease" MappingType="XRef" MappingValue="613153" MappingRef="OMIM">
        <MedGen CUI="C3150413" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7328335" TraitType="Disease" MappingType="XRef" MappingValue="607155" MappingRef="OMIM">
        <MedGen CUI="C1846672" Name="Autosomal recessive limb-girdle muscular dystrophy type 2I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

